These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30577314)

  • 21. Laboratory-acquired West Nile virus infections--United States, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Dec; 51(50):1133-5. PubMed ID: 12537288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excretion of West Nile virus in urine during acute infection.
    Barzon L; Pacenti M; Franchin E; Pagni S; Martello T; Cattai M; Cusinato R; Palù G
    J Infect Dis; 2013 Oct; 208(7):1086-92. PubMed ID: 23821721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. West Nile virus activity--United States, September 26-October 2, 2002, and investigations of West Nile virus infections in recipients of blood transfusion and organ transplantation.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Oct; 51(39):884, 895. PubMed ID: 12375691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human case of West Nile neuroinvasive disease in Portugal, summer 2015.
    Zé-Zé L; Proença P; Osório HC; Gomes S; Luz T; Parreira P; Fevereiro M; Alves MJ
    Euro Surveill; 2015; 20(38):. PubMed ID: 26535915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of West Nile Virus Transmission and Epidemiology.
    Troupin A; Colpitts TM
    Methods Mol Biol; 2016; 1435():15-8. PubMed ID: 27188546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. West Nile viremic blood donors and risk factors for subsequent West Nile fever.
    Brown JA; Factor DL; Tkachenko N; Templeton SM; Crall ND; Pape WJ; Bauer MJ; Ambruso DR; Dickey WC; Marfin AA
    Vector Borne Zoonotic Dis; 2007; 7(4):479-88. PubMed ID: 17979539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of ABO, D, and Lewis blood groups and HLA Class I and Class II alleles with West Nile virus Lineage 2 disease outcome in Greece, 2010 to 2013.
    Politis C; Parara M; Kremastinou J; Hasapopoulou E; Iniotaki A; Siorenta A; Richardson C; Papa A; Kavallierou L; Asariotou M; Katsarou O; Mougiou A; Dadiotis L; Alexandropoulou Z; Megalou A; Magoula E; Papadopoulou M; Pervanidou D; Baka A; Hadjichristodoulou C
    Transfusion; 2016 Aug; 56(8):2115-21. PubMed ID: 27245377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The epidemic of West Nile virus in the United States, 2002.
    O'Leary DR; Marfin AA; Montgomery SP; Kipp AM; Lehman JA; Biggerstaff BJ; Elko VL; Collins PD; Jones JE; Campbell GL
    Vector Borne Zoonotic Dis; 2004; 4(1):61-70. PubMed ID: 15018774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. West Nile virus and kidney disease.
    Barzon L; Pacenti M; Palù G
    Expert Rev Anti Infect Ther; 2013 May; 11(5):479-87. PubMed ID: 23627854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. West Nile virus: should pediatricians care?
    Smith JC; Mailman T; MacDonald NE
    J Infect; 2014 Nov; 69 Suppl 1():S70-6. PubMed ID: 25138381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human West Nile virus infection in Bosnia and Herzegovina.
    Ahmetagić S; Petković J; Hukić M; Smriko-Nuhanović A; Piljić D
    Med Glas (Zenica); 2015 Feb; 12(1):47-51. PubMed ID: 25669336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase in West Nile virus infections imported to Germany in 2012.
    Gabriel M; Emmerich P; Frank C; Fiedler M; Rashidi-Alavijeh J; Jochum C; Günther S; Auerhammer K; Rupprecht HJ; Blank RT; Sacher N; Pertzborn L; Stark K; Schrauzer T; Schmidt-Chanasit J
    J Clin Virol; 2013 Nov; 58(3):587-9. PubMed ID: 24055268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of blood transfusion recipients with West Nile virus infections.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Sep; 51(36):823. PubMed ID: 12269472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. West Nile virus neuroinvasive disease.
    Davis LE; DeBiasi R; Goade DE; Haaland KY; Harrington JA; Harnar JB; Pergam SA; King MK; DeMasters BK; Tyler KL
    Ann Neurol; 2006 Sep; 60(3):286-300. PubMed ID: 16983682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. West Nile virus activity - United States, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jul; 59(25):769-72. PubMed ID: 20592686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance of West Nile virus disease, Tel Aviv district, Israel, 2005 to 2010.
    Kopel E; Amitai Z; Bin H; Shulman LM; Mendelson E; Sheffer R
    Euro Surveill; 2011 Jun; 16(25):. PubMed ID: 21722612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Variability of West Nile Virus in U.S. Blood Donors from the 2012 Epidemic Season.
    Grinev A; Chancey C; Volkova E; Añez G; Heisey DA; Winkelman V; Foster GA; Williamson P; Stramer SL; Rios M
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004717. PubMed ID: 27182734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of West Nile virus infection in solid organ transplant recipients.
    Freifeld AG; Meza J; Schweitzer B; Shafer L; Kalil AC; Sambol AR
    Transpl Infect Dis; 2010 Apr; 12(2):120-6. PubMed ID: 19874565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. West Nile virus neuroinvasive disease incidence in the United States, 2002-2006.
    Lindsey NP; Kuhn S; Campbell GL; Hayes EB
    Vector Borne Zoonotic Dis; 2008; 8(1):35-9. PubMed ID: 18237264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. West Nile virus among hospitalized, febrile patients: a case for expanding diagnostic testing.
    Whitney EA; Heilpern KL; Woods CW; Bahn CC; Franko EA; Del Rio C; Silk BJ; Ratcliff JJ; Bryant KA; Park MM; Watkins SJ; Caram LB; Blumberg HM; Berkelman RL
    Vector Borne Zoonotic Dis; 2006; 6(1):42-9. PubMed ID: 16584326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.